Millburn, NJ September 22nd 2026, Bluecrux and Astrix today announce a strategic partnership to accelerate the adoption of intelligent laboratory planning and scheduling across the United States, Bluecrux's fastest-growing market. Bluecrux, a Leader in the 2026 Gartner® Magic Quadrant™ for Specialist Supply Chain Strategy, Planning and Operations Consulting, and the company behind Binocs™, the global #1 SaaS platform for planning and scheduling in quality control laboratories and cell & gene therapy production is partnering with Astrix, the leader in delivering innovative pharmaceutical technology services for the life science community. Together, the two companies will accelerate the delivery of proven laboratory planning expertiseand technology to a broader range of U.S. pharmaceutical and biotech organizations looking to digitally transform their lab operations and processes.
Bluecrux has spent 15 years transforming how the world's most complex value chains operate, combining a specialized consulting practice with its own technologies. Its laboratory operations consultants have redesigned QC planning processes, roles, and governance at many of the world's largest pharmaceutical and biotech companies. That consulting depth, alongside the Binocs™ platform, is what has made Bluecrux the leading laboratory planning and scheduling and earned it recognition by Gartner™ as one of the world's top 20 supply chain partners.
Binocs™ is the global #1 SaaS platform for scheduling, capacity planning, and resource management in QC and advanced therapies. Already proven across leading pharma organizations including Eli Lilly, GSK, Novartis and many more, it helps laboratories bring people, instruments, and 22workload together in one planning system.
As one of the leading providers of specialized pharmaceutical technology services, Astrix brings one of the largest footprints in laboratory informatics services and domain expertise, with proven strength in AI, data and digital strategy, system selection, implementation, and change management. The partnership is therefore not about closing a capability gap on either side. It is about scale, speed, and expertise in a market where demand for intelligent laboratory planning is growing daily.
"When we look for parters at Astrix we look for companies that share our mission and vision for the life science community”, said John Moran, Chief Commercial Officer at Astrix. “The combination of Astrix and Bluecrux is a clear win-win for not only clients but the market as a whole as it meets with our goal of accelerating digital transformation for the life science community.”
US pharma and biotech laboratories are under sustained pressure to release more products faster, with flat headcount and constrained instrument capacity. Planning and scheduling areamongst the fastest levers available to unlock that capacity and one of the least digitalized.
Through the partnership, the two companies will collaborate on joint opportunities in the US market. Where laboratories select Binocs, Bluecrux and Astrix consultants can work side by side on implementation and adoption, shortening the path from decision to measurable value. The partnership is non-exclusive, and Astrix continues to advise its clients independently of any single technology.
"The US market is the fastest growth area for Binocs," said Ben Van Lancker, Partner and VP for Binocs Technology. “The Astrix partnership is designed to support that demand head-on. We have the market leading platform, and deep planning expertise and experience in redesigning how laboratories plan and schedule their work. Astrix brings proven, scalable and deep laboratory expertise. Together we can bring intelligent planning to many more US laboratories, and much faster than either of us could alone."
About Bluecrux
Founded in 2011, Bluecrux is the leading value chain innovation company, recognized as a Leader in the Gartner® Magic Quadrant™ for Specialist Supply Chain Strategy, Planning and Operations.
Our mission is to transform today’s supply chains into the smart, efficient, and fully integrated value chains of tomorrow. We do that through our specialized consulting expertise and AI-powered technologies, Axon™, Binocs™, and Helion™.
We work with some of the world’s largest companies (Johnson & Johnson, GSK, Roche, Bridgestone, AkzoNobel, Beiersdorf, Kenvue, argenx, Zoetis, and more), helping them optimize and future-proof their value chains. Our global presence spans Europe, the US, and APAC, ensuring we’re always close to the action.
To discover more, please visit www.bluecrux.com
About Astrix
Astrix is the global leader in delivering innovative strategies and solutions to the life sciences industry. Powered by world-class people, proven processes, and advanced technology, Astrix partners with clients to drive measurable improvements in business performance, scientific advancement, and clinical outcomes—ultimately driving towards a goal of improving quality of life.
Founded by scientists to address the industry’s most complex challenges, Astrix provides a growing portfolio of strategic and technical services that deliver immediate impact while enabling long-term digital transformation. Our deep expertise spans strategic planning, data strategy, AI/ML readiness and technologies, lab informatics, and modern clinical operations and eClinical platforms so we can successfully deliver solutions that have high impact and drive better outcomes for everyone.
To learn more about Astrix’s market-leading pharmaceutical technology services, visit www.astrixinc.com.
